Your Article Summary
See Latest ArticlesLiver resection for metastatic colorectal cancer in the presence of extrahepatic disease
Annals of Surgical Oncology, 07/01/09
Carpizo DR et al. - In a study to assess the use of liver resection for metastatic colorectal cancer (mCRC) in the presence of extrahepatic disease (EHD), there appears to be a role for surgery in highly selected pts with a single site of EHD amenable to complete resection. Unlike pts with liver-only disease, however, the goals of surgery must not be viewed as potentially curative.
Methods- This review was restricted to published data in the English language identified by searches of MEDLINE and Pubmed databases as well as reference lists of recent review articles on subjects of surgery for mCRC.
- 5-yr survival after resection is worse than in pts with liver-only disease but approximates the survival rates seen in pts with resected liver-only metastases in the era prior to the use of modern chemotherapy.
- Recurrence occurs in the great majority of pts.
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
Localized resection for colon cancer
Surgical Oncology, 11/04/09
Effect of bevacizumab in older patients with metastatic colorectal cancer: Pooled analysis of four randomized studies
Journal of Cancer Research & Clinical Oncology, 11/17/09
A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma
American Journal of Clinical Nutrition, 10/29/09